Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Hosny Salama, Pravin Punamiya, Andrew de la Torre, Michael Lange, Hassan Ahmed, Ismail Elchagie, Abdel Rahman Zekri, Eman Medhat, Abeer Bahnasi, Mohammed Rabbat
  • Journal of Hepatocellular Carcinoma, June 2015, Dove Medical Press
  • DOI: 10.2147/jhc.s60864

Ambovex Article

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Dr Pravin A Punamiya and Andrew N de la Torre